Publication | Open Access
First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer
29
Citations
27
References
2020
Year
Our first-in-human results demonstrate the safety and feasibility of noninvasive <i>in vivo</i> detection of tumor epichaperomes using <sup>124</sup>I-PU-H71 PET, supporting clinical development of PU-H71 and other epichaperome-targeted therapeutics.
| Year | Citations | |
|---|---|---|
Page 1
Page 1